These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 30411515)
1. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity. Wang R; Yang F; Qing L; Huang R; Liu Q; Li X Clin Obes; 2019 Feb; 9(1):e12289. PubMed ID: 30411515 [TBL] [Abstract][Full Text] [Related]
2. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Dai YN; Zhu JZ; Fang ZY; Zhao DJ; Wan XY; Zhu HT; Yu CH; Li YM Metabolism; 2015 Dec; 64(12):1667-73. PubMed ID: 26476959 [TBL] [Abstract][Full Text] [Related]
3. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. Sayın O; Tokgöz Y; Arslan N J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600 [TBL] [Abstract][Full Text] [Related]
4. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233 [TBL] [Abstract][Full Text] [Related]
5. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease. Eklioğlu BS; Atabek ME; Akyürek N; Alp H J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):222-7. PubMed ID: 26831557 [TBL] [Abstract][Full Text] [Related]
7. Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease? De Munck TJI; Boesch M; Verhaegh P; Masclee AAM; Jonkers D; van Pelt JF; du Plessis J; Korf H; Nevens F; Koek GH; Van der Merwe S; Verbeek J PLoS One; 2021; 16(5):e0251822. PubMed ID: 33989346 [TBL] [Abstract][Full Text] [Related]
8. Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review. Ziqubu K; Dludla PV; Mthembu SXH; Nkambule B; Mazibuko-Mbeje SE Adipocyte; 2024 Dec; 13(1):2390833. PubMed ID: 39162358 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents. Liang S; Cheng X; Hu Y; Song R; Li G Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912 [TBL] [Abstract][Full Text] [Related]
10. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. Angın Y; Arslan N; Kuralay F Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597 [TBL] [Abstract][Full Text] [Related]
11. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696 [TBL] [Abstract][Full Text] [Related]
12. Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease. Amin S; El Amrousy D; Elrifaey S; Gamal R; Hodeib H J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):117-121. PubMed ID: 28991837 [TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children. Prokopowicz Z; Malecka-Tendera E; Matusik P Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716 [TBL] [Abstract][Full Text] [Related]
14. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398 [TBL] [Abstract][Full Text] [Related]
15. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease. Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480 [TBL] [Abstract][Full Text] [Related]
17. Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children. Hu W; Wang M; Yin C; Li S; Liu Y; Xiao Y Acta Paediatr; 2018 Feb; 107(2):322-327. PubMed ID: 28981167 [TBL] [Abstract][Full Text] [Related]
18. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833 [TBL] [Abstract][Full Text] [Related]
19. Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity. Hatipoğlu N; Doğan S; Mazıcıoğlu MM; Kurtoğlu S J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):32-9. PubMed ID: 26758497 [TBL] [Abstract][Full Text] [Related]
20. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children. Özhan B; Ersoy B; Özkol M; Kiremitci S; Ergin A Turk J Pediatr; 2016; 58(5):518-523. PubMed ID: 28621093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]